AKN-028 acetate

• CAT Number: I042851
• Molecular Formula: C19H18N6O2
• Molecular Weight: 362.39
• Purity: ≥95%
• Synonyms: acetic acid;3-N-(1H-indol-5-yl)-5-pyridin-4-ylpyrazine-2,3-diamine
• InChI: InChI=1S/C17H14N6.C2H4O2/c18-16-17(22-13-1-2-14-12(9-13)5-8-20-14)23-15(10-21-16)11-3-6-19-7-4-11;1-2(3)4/h1-10,20H,(H2,18,21)(H,22,23);1H3,(H,3,4)
• InChIKey: KMFGKUDUSUBTMI-UHFFFAOYSA-N
• SMILES: CC(=O)O.C1=CC2=C(C=CN2)C=C1NC3=NC(=CN=C3N)C4=CC=NC=C4

AKN-028 acetate（Cat No.:I042851）is a novel small molecule inhibitor that targets the signaling pathways involved in cancer cell proliferation and survival. Specifically, it inhibits certain kinases that play a crucial role in tumor progression and resistance to treatment. AKN-028 acetate shows potential in addressing a variety of cancers, including those that are resistant to conventional therapies. By disrupting key cellular processes, it may reduce tumor growth, promote apoptosis, and enhance the effectiveness of other cancer treatments. Ongoing research is focused on evaluating its safety and efficacy in clinical trials for cancer therapy.